References
- Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 2004–2005. CBTRUS, Chicago, IL, USA (2004).
- Pfund Z, Szapary L, Jaszberenyi O, Nagy F, Czopf J. Headache in intracranial tumors. Cephalgia 19(9), 787–790 (1999).
- Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J. Nurs. Schol. 36(3), 197–206 (2004).
- Marks DR, Rapoport AM. Practical evaluation and diagnosis of headache. Sem. Neurol.17(4), 307–312 (1997).
- Wick W, Kuker W. Brain edema in neurooncology: radiological assessment and management. Onkologie 27(3), 261–266 (2004).
- Physicians’ Desk Reference (58th edition). Medical Economics Company, Montvale, NJ, USA (2004).
- Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 52(3), 617–622 (1999).
- Gilbert M, Armstrong T. Management of seizures in the adult patient with cancer. Cancer Practice 3(3), 143–149 (1995).
- Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. American Academy of Neurology MN, USA (2000).
- Sawaya RE, Ligon BL. Thromboembolic complications associated with brain tumors. J. Neuro-oncol. 22(2), 173–181 (1994).
- Norris LK, Grossman SA. Treatment of thromboembolic complications in patients with brain tumors. J. Neuro-oncol. 22(2) 127–137 (1994).
- Wen PY, Marks PW. Medical management of patients with brain tumors. Curr. Opin.Oncol. 14(3), 299–307 (2002).
- Rabbitt J, Page MS. Selected complications in neuro-oncology patients. Sem. Oncol. Nurs. 14(1), 53–60 (1998).
- Gadisseux P, Ward JD, Young HF, Becker DP. Nutrition and the neurosurgical patient. J. Neurosurg. 60(2), 219–232 (1984).
- Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J. Neuro-oncol. 57(1), 41–49 (2002).
- Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiforme. Oncol. Nurs. For. 26(5), 921–925 (1999).
- Hahn CA, Dunn RH, Logue PE et al. Prospective study of neuropsychological testing and quality-of-life assessment of adults with primary malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 55(4), 992–999 (2003).
- Taphoorn MJ. Neurocognitive sequelae in the treatment of low-grade gliomas. Sem. Oncol. 30(6 Suppl. 19), 45–48 (2003).
- Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psycho-Oncol. 6(3), 169–177 (1997).
- Kirshblum S, O’Dell MW, Ho C, Barr K. Rehabilitation of persons with central nervous system tumors. Cancer 92(4 Suppl.), 1029–1038 (2001).
- Huang ME, Wartella JE, Kreutzer JS. Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Arch. Phys. Med. Rehabil. 82(11), 1540–1546 (2001).
- Newton HB, Malkin, MG. Ethical issues in neuro-oncology. Sem. Neurol. 17(3), 219–226 (1997).
- Voltz R, Borasio GD. Palliative therapy in the terminal stage of neurological disease. J. Neurol. 244(Suppl. 4), S2–10 (1997).
Website
- Agency for Healthcare Research. Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. AHRQ Publication Number 03-E012 www.ahcpr.gov/clinic/epcsums/dvtsum.htm (Accessed March 2005)